Navigation Links
Nephros Reports 2011 Fourth Quarter and Full Year Financial Results
Date:3/22/2012

share for the fourth quarter of 2011 versus a net loss of approximately $665,000 or $0.34 per basic and diluted common share in the fourth quarter of 2010. Nephros' net loss decreased $27,000 primarily due to an approximate $74,000 reduction in other expenses.  Other expense of approximately $15,000 in interest expense and $50,000 of debt issuance costs were incurred during the three months ended December 31, 2010. These expenses were not incurred during the three months ended December 31, 2011.

Outlook

Under the licensing agreement with Bellco, S.r.l., Nephros began 2012 with receipt of the second installment payment of euro 750,000 in January.  The third and final installment payment of euro 600,000 is payable to Nephros on January 15, 2013.  Beginning on January 1, 2015, Nephros will receive royalty payments from Bellco as part of the license agreement.

On August 11, 2011, Nephros filed a new 510(k) application with the FDA for clearance of the Company's hemodiafiltration (HDF) system for end-stage renal disease.   On November 8, 2011 the Company received the initial FDA review of its new 510(k) application (K112314), which included a request for additional information.  The Company provided answers to the FDA's request in early February 2012.  The Company's response is subject to the FDA's standard review period of 90 days; however, the Company has no assurance that a response will be received within this time period.  Nephros believes that, if approved, its technology would be the first FDA-approved on-line HDF therapy available in the U.S.

For 2011, Nephros recorded approximately $618,000 of sales related to its ultrafiltration products, a 23% increase over the prior year.  With the recent additions of Shane Sullivan as Director of U.S. Sales and Dr. Joseph Cervia as our strategic consultant, Nephros is working to formalize its marketing approach to the hospital infection control
'/>"/>

SOURCE Nephros, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products
2. Nephros Reports 2009 Third Quarter Financial Results
3. Nephros Signs Canadian Distribution Agreement with Bellco Health Care Inc.
4. Nephros Signs Development Agreement with STERIS
5. Nephros Reports 2010 First Quarter Financial Results
6. Nephros and AmeriWater Announce Dual Stage Ultrafilters to be a Standard Component of MRO Series Water Treatment Systems
7. Nephros Receives Formal Response from FDA for 510(k) Application for Hemodiafiltration System
8. Nephros Reports 2010 Second Quarter Financial Results
9. Nephros Completes Bridge Financing and Announces Stockholder Rights Offering
10. Nephros Reports 2010 Third Quarter Financial Results
11. Nephros Rights Offering Registration Statement Declared Effective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014  Hill-Rom Holdings, Inc. ... to a management presentation at the Morgan Stanley Global ... EDT. You are invited to listen to ... http://ir.hill-rom.com/events.cfm or access it directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP ... available one hour after conclusion of the live event ...
(Date:8/27/2014)... An experimental drug designed to help regulate the blood,s iron ... of inflammation, according to results from the first human ... Blood , the Journal of the American ... a condition that occurs when red blood cells are in ... has anemia, the body does not get enough oxygen, since ...
(Date:8/27/2014)... , Aug. 27, 2014 ... research report is available in its ... for Application and Approval of Imported ... Practices (2014 Edition) ... Now, Chinese regulations on medical ...
Breaking Medicine Technology:Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 5Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 6Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 7Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 8Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 9Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 10
(Date:8/27/2014)... Houston, TX (PRWEB) August 27, 2014 ... The reality is that depression has a mortality ... those with bi-polar disorder is slightly less, though it's ... of roughly 7%. In order to properly treat ... schizophrenia, and bi-polar, medication must be taken as directed. ...
(Date:8/27/2014)... Illinois (PRWEB) August 27, 2014 Aspirus ... project in the US with Buzz™ Digital O.R. at ... foundation of all 13 new operating rooms will be ... and management. This integrative system supports planning, navigation, imaging ... an advanced fusion of intuitive software and hardware all ...
(Date:8/27/2014)... of the leading purveyors of real and synthetic hair wigs, hair ... its products, for the coming Labor Day. , People searching for ... hair products in two ways: when they spend more than $89 ... LABOR10; while when they spend more than $299, they can save ... code is needed when securely checkout, there are about 50 products ...
(Date:8/27/2014)... is the second leading cause of cancer-associated death ... the difficulty in treating this cancer using conventional ... etoposide or combinations therein. This may be attributed ... to reach in a sufficient concentration in the ... harmful to the rest of the body. Considering ...
(Date:8/27/2014)... which repel water and oil and are persistent ... processing. These characteristics have made the fluorochemicals useful ... for food paper and board. , The problem ... break down and accumulate in both humans and ... harmful health effects, such as cancer, increased cholesterol ...
Breaking Medicine News(10 mins):Health News:MedicationDiscountCard.com now Makes Brintellix and Mental Illness Medications More Affordable with Discount Cards 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 3Health News:UniWigs Is Offering A Big Sale for Labor Day on All Its Products 2Health News:The thunder god vine, assisted by nanotechnology, could shake up future cancer treatment 2Health News:The thunder god vine, assisted by nanotechnology, could shake up future cancer treatment 3Health News:Leading scientists call for a stop to non-essential use of fluorochemicals 2Health News:Leading scientists call for a stop to non-essential use of fluorochemicals 3
... new findings don,t apply to men , , MONDAY, Aug. ... against skin cancer and may actually boost the risk, ... study. , "Taking into consideration our results, we are ... in sun-seekers and people wanting to look tanned [using ...
... A patients expectations about the side effects of ... other side effects. Worries about severe allergic reactions to ... recent study from the Lineberger Comprehensive Cancer Center at ... Vanderbilt-Ingram Comprehensive Cancer Center and the Sarah Canon Cancer ...
... researchers say , , MONDAY, Aug. 20 (HealthDay News) -- ... C. Hurlbert wondered why all the products aimed at her ... professor of visual neuroscience at Newcastle University in England, Hurlbert ... whether girls really do prefer pink. The answer, as outlined ...
... Findings probably apply to males of other ethnicities, researchers say ... increases the risk of stroke in Chinese men, a new ... were 40 and older and had no history of stroke ... the men was conducted between 1999 and 2000, researchers found ...
... 20, 2007 - Lissamine green sounds like the latest ... something you would want to get in your eyes. ... staining patterns that are key to diagnosing dry eye ... for treating the potentially sight-stealing disease, new research at ...
... between brain cells along hairlike extensions called axons. For ... just transmit information they can turn the signal ... finding may help scientists develop treatments for psychiatric disorders ... thought that different parts of the brain do not ...
Cached Medicine News:Health News:Antioxidant Supplements May Raise Women's Skin Cancer Risk 2Health News:Antioxidant Supplements May Raise Women's Skin Cancer Risk 3Health News:Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US 2Health News:Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US 3Health News:Girls Really Do Prefer Pink 2Health News:Heavy Drinking Boosts Stroke Risk for Chinese Men 2Health News:Eye-staining technique offers early detection for dry eye syndrome 2Health News:Eye-staining technique offers early detection for dry eye syndrome 3Health News:Brain cells work differently than previously thought 2
Inoculum Broth...
... Molecular Biology Buffers are ready-to-use solutions ideal ... applications. Each reagent is prepared with 18 ... filter, and filled into sterile bottles., ... control standards to ensure lot-to-lot consistency. ...
1.2% Tryptone, 2.4% Yeast Extract, 0.4% Glycerol, with 100ml of 10x Phosphate buffer supplement (0190-01)....
1.0% Casein digest (NZ amine), 0.5% Sodium Chloride....
Medicine Products: